Weissella cibaria relieves gut inflammation caused by Escherichia coli through inflammation modulation and gut microbiota regulation

The emergence of multi-drug resistant (MDR) pathogens has considerably challenged the development of new drugs. Probiotics that inhibit MDR pathogens offer advantages over chemical antibiotics and drugs owing to their increased safety and fewer side effects. This study reported that Weissella cibaria P-8 isolated from pickles showed excellent antibacterial activity against intestinal pathogens; particularly the antibacterial activity against MDR Escherichia coli B2 was the strongest